scholarly journals Troponins in scuba divers with immersion pulmonary edema

2018 ◽  
Vol 38 (5) ◽  
Author(s):  
Marion Marlinge ◽  
Pierre Deharo ◽  
Fabrice Joulia ◽  
Mathieu Coulange ◽  
Donato Vairo ◽  
...  

Immersion pulmonary edema (IPE) is a serious complication of water immersion during scuba diving. Myocardial ischemia can occur during IPE that worsens outcome. Because myocardial injury impacts the therapeutic management, we aim to evaluate the profile of cardiac markers (creatine phosphokinase (CPK), brain natriuretic peptide (BNP), highly sensitive troponin T (TnT-hs) and ultrasensitive troponin I (TnI-us) of divers with IPE. Twelve male scuba divers admitted for suspected IPE were included. The collection of blood samples was performed at hospital entrance (T0) and 6 h later (T0 + 6 h). Diagnosis was confirmed by echocardiography or computed-tomography scan. Mean ± S.D. BNP (pg/ml) was 348 ± 324 at T0 and 223 ± 177 at T0 + 6 h (P<0.01), while mean CPK (international units (IUs)), and mean TnT-hs (pg/ml) increased in the same times 238 ± 200 compared with 545 ± 39, (P=0.008) and 128 ± 42 compared with 269 ± 210, (P=0.01), respectively; no significant change was observed concerning TnI-us (pg/ml): 110 ± 34 compared with 330 ± 77, P=0.12. At T0 + 6 h, three patients had high TnI-us, while six patients had high TnT-hs. Mean CPK was correlated with TnT-hs but not with TnI-us. Coronary angiographies were normal. The increase in TnT during IPE may be secondary to the release of troponin from non-cardiac origin. The measurement of TnI in place of TnT permits in some cases to avoid additional examinations, especially unnecessary invasive investigations.

2011 ◽  
Vol 57 (6) ◽  
pp. 826-829 ◽  
Author(s):  
James A de Lemos ◽  
David A Morrow ◽  
Christopher R deFilippi

Abstract The development of highly sensitive assays for cardiac troponin T (hs-cTnT)4 and cardiac troponin I (hs-cTnI) represents the latest technological advance in a field that has witnessed continual progression toward more sensitive and more precise tools for detecting cardiac injury. The hs-cTnT assay, for example, can detect cTnT concentrations 10-fold lower than the current fourth-generation assay, with high precision at the myocardial infarction (MI) detection limit. Despite the potential for such evolution to improve patient care, clinicians, including practicing cardiologists, often find themselves poorly prepared for the introduction of more-sensitive assays, because they fail to consider the implications of increasing sensitivity on the interpretation of the test results. We believe that highly sensitive troponin assays offer new opportunities to improve cardiovascular health, but they also present challenges in the areas in which troponin testing is most commonly used today.


2012 ◽  
Vol 68 (5) ◽  
pp. 287-293 ◽  
Author(s):  
J.K. Jensen ◽  
T. Ueland ◽  
P. Aukrust ◽  
L. Antonsen ◽  
S.R. Kristensen ◽  
...  

2021 ◽  
Vol 11 (02) ◽  
pp. 183-198
Author(s):  
Hekmat Mohamed ◽  
Maha Youssef ◽  
Manal Abdel-Salam ◽  
Shayma A. Mohammed

2020 ◽  
Vol 73 (12) ◽  
pp. 1065-1066
Author(s):  
Elena Ferrer-Sistach ◽  
Josep Lupón ◽  
Germán Cediel ◽  
Elena Revuelta-López ◽  
Antoni Bayés-Genís

Sign in / Sign up

Export Citation Format

Share Document